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PORCINE MODEL FOR STUDYING THE PASSAGE OF
NON-DEPOLARIZING NEUROMUSCULAR BLOCKERS
THROUGH THE BLOOD-BRAIN BARRIER
A. WERBA, H. GILLY, M. WEINDLMAYR-GOETTEL, C. K. SPISS,
K. STEINBEREITHNER, T. CZECH AND S. AGOSTON
SUMMARY
A method has been developed for blood-brain
barrier disruption to provide reproducible access to
the cerebrospinal fluid of the cerebellomedullary
cistern. The technique was used successfully to
investigate transfer of pancuronium to the cerebral
CSF compartment in pigs. After osmotic disruption
of the blood-brain barrier, pancuronium concen-
trations increased significantly in the cerebrospinal
fluid.
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It is accepted generally that quaternary compounds
with a molecular centre carrying a strong positive
charge do not cross the blood-brain barrier (BBB) in
concentrations great enough to affect the brain. In
spite of this, several neuromuscular blocking drugs
have been shown to produce, not only EEG evidence
of arousal reactions, but also decreases in frequency
and amplitude in animals with disrupted BBB, which
may indicate a depressant effect on the activating
system of the medulla oblongata [1]. Therefore,
interest has been focused on the passage of neuro-
muscular blockers through the supposedly com-
promised BBB and their possible toxic effects on
cholinergic pathways in brainstem and midbrain
structures [2]. If neuromuscular blocking agents do
enter the CNS in large concentrations, recovery in
patients with altered states of BBB might be delayed
because of anticholinergic effects in midbrain struc-
tures (e.g. thalamus) [3].
There are few data on the passage of non-
depolarizing neuromuscular blockers into the cere-
brospinal fluid (CSF) in man [4, 5]. Furthermore,
neither qualitative nor quantitative assessment of
neuromuscular blocking drug penetration into the
CSF before and after BBB disruption has been
investigated under well controlled conditions.
The aim of this study was to develop a reliable
technique for BBB disruption which also provides
convenient access to the CSF of the cerebello-
medullary cistern in the pig. After the model had
been developed, we investigated the passage of
pancuronium through the intact and disrupted BBB.
MATERIALS AND METHODS
Experimental procedure
After approval by the committee on animal
research, we studied eight previously tested MH-
free pigs (German breed) weighing 20-22 kg. An-
aesthesia was induced by i.v. injection of thiopentone
10 mg kg"1 and maintained by a continuous infusion
of 10—15 mg kg"1 h"1. Additional opioids or inhal-
ation agents were not administered. Tracheotomy
was performed and ventilation using an oxygen-air
mixture (Flo, 0-4) was adjusted to maintain arterial
PaCOt within normal limits (4.6-5.3 kPa) as assessed
by capnography and intermittent blood-gas analysis.
Ringer solution was infused i.v. at a rate of
3-5 ml kg"1 as required to keep haemodynamic
variables within 10% of control values. In order to
avoid excessive filling of the urinary bladder,
suprapubic puncture and drainage was performed.
An indwelling polyethylene catheter (0.9 mm i.d.)
was placed in the right femoral artery for pressure
recording and blood sampling. After exposure and
ligation, the left common carotid artery (CCA) was
cannulated (polyethylene cannula 1 mm i.d.), with
the tip of the catheter just proximal to the occipital
artery, for administration of hypertonic mannitol.
At first, the effects of continuous proximal CCA
ligation on BBB integrity were investigated in three
animals. After 60 min of CCA ligation, 2 % Evan's
blue 3 ml kg"1 was injected slowly via a peripheral
vein for determination of BBB integrity. After an
equilibration period of 10 min, the animal was killed
with potassium chloride and the brain was removed
immediately.
For cisternal catheter positioning, the animals
were placed in a right lateral position with maximal
flexion of the head to provide optimal access to the
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occipital bone. A midline incision was made from
3 cm proximal to approximately 13 cm distal to the
external occipital protuberance. The muscles of the
neck were separated by blunt dissection, the occipital
bone exposed and the dorsal edge of the foramen
magnum identified. The area between the nuchal
ridge and the right atlanto-occipital junction was
exposed. An 11-mm hole was drilled to give access to
the dura mater; its position was selected exactly 1 cm
cranial to the base of the occiput and approximately
1 cm medial to a vertical line through the right
atlanto-occipital junction in order to avoid bleeding
from extradural veins or from the median occipital
sinus. After incision of the dura, cannulation of the
cerebellomedullary cistern was performed by moving
a polyethylene catheter (i.d. 0.5 mm, length 15 cm)
along the dura approximately 2 cm in a medial and
caudal direction. Correct position within the cisterna
magna was confirmed by slow aspiration of clear
CSF. Before insertion of the catheter, its tip was
rounded by heating to avoid vascular lesions or
damage of pial structures. Free flow of CSF was
facilitated by two side holes within 5 mm of the tip.
The drill hole was sealed with Histacryl to prevent
both leakage of CSF and accidental removal of the
catheter.
After completion of the surgical procedure and
cisternal catheter placement, 25 % mannitol
3 ml kg"1 was injected slowly over 30 s into the left
CCA to induce osmotic disruption of the BBB. The
degree of BBB disruption was determined by
assessing the staining of the cortex subsequent to
injection of Evan's blue dye at the end of each
experiment.
The staining of the brain was graded as follows:
grade 0 = no staining; grade 1 + = just noticeable
staining; grade 2+ = moderate blue staining; grade
3 + = dark blue staining [6, 7]. Correct catheter
position in the cisterna magna was checked at
autopsy.
Pancuronium assay in plasma and CSF
The concentration of pancuronium in CSF before
and after mannitol-induced BBB disruption and
plasma concentrations were measured by high press-
ure liquid chromatography [8]. Plasma and internal
standard were mixed with potassium iodide—glycine
buffer and dichlormethane for 30 s. After centri-
fugation, the bottom phase was evaporated to dryness
at 45 °C under a stream of nitrogen. The dry residue
was reconsisted in 250 îl of the HPLC eluent for
further analysis. Liquor samples were analysed
without extraction. A model 116 HPLC pump with
a 210 A sample injection valve (Beckman Instr.) was
used. The separation was carried out on a Nova Pak
C18 column (Waters—Millipore) with a mobile phase
consisting of sodium dihydrogen phosphate
(NaHjPO4) 0.1 mol litre"1 (pH = 3.0, orthophos-
phoric acid <H3POj) adjusted),"97l0-dimethoxy-
anthracene-2-sulfonate (DAS) 0.11 mmol litre"1
heptansulfonate (HS) 0.11 mmol litre"1 in water-
-dioxane (85:15 v/v) at a flow rate of 1 ml min"1.
For the purpose of the on-line post-column ion
pair extraction, dichloroethane was added by a
880 PU-Jasco solvent delivery system and mixed
with the HPLC eluent using a small deadspace
volume T-piece. The extraction was performed in a
3.2-mx 1-mm i.d. coiled Teflon capillary connected
to a sandwich-type phase separator. The phase
separator consisted of a PTFE disc with a 42 x 1.5-
mm groove sandwiched between two stainless-steel
blocks. The split ratio of the phase separator was
adjusted with a microcontrol needle valve BMVC
(SGE) mounted in the outlet of the upper steel
block.
The fluorimetric detector (LS-2B, Perkin Elmer)
was set at 385 nm (excitation) and 452 nm (emission).
After each series of analyses, the HPLC-column was
flushed with water (approx. 15 ml) and methanol
(approx. 75 ml). The HPLC-system was operated
and the chromatograms were recorded and processed
with System Gold chromatography software (Beck-
man Instr.).
Linearity was observed (r = 0.9956) over a range
of 0.05-10 jig ml"1. The extraction recovery was
approximately 30-70% compared with that of
unextracted standard samples. The limit of detection
for all substances (pancuronium and its metabolites)
was approximately 5 ng ml"1.
Pancuronium penetration into the cerebral CSF
compartment before and after disruption of the
blood-brain barrier
Having established the method in preliminary
studies, we applied the technique in eight additional
experiments.
After completion of the operative procedure,
neuromuscular monitoring was commenced using
supramaximal (2-4-mA) stimulation of the common
peroneal nerve with stimuli of 0.2 ms duration at a
rate of 0.1 Hz and anterior tibial muscle mechano-
myography. After a stabilization period of 10 min, a
bolus dose of pancuronium 220 |ig kg"1 (2 x EDM)
was given i.v. and, after spontaneous twitch recovery
to 10% of control, an infusion of pancuronium was
administered continuously for 60 min; the infusion
rate was adjusted to keep neuromuscular block at
85-90 % of control. Blood and CSF samples were
obtained 2, 10, 30, 60 and 90 min after the admin-
istration of the bolus dose of pancuronium.
After complete spontaneous recovery of neuro-
muscular function, each animal was given 25 %
mannitol 3 ml kg"1 to disrupt the BBB, and the
animal was subjected again to the programme as
described above.
At the end of the experiment, Evan's blue was
injected i.v.; 10 min later the animal was killed and
the brain removed immediately for assessment of the
level of brain staining as evidence for BBB dis-
ruption.
Statistics
Pancuronium concentrations in plasma and CSF
were assessed statistically using the Wilcoxon test for
paired data. Level of significance was assumed to be
95 % (P < 0.05). Data are presented as mean values
(SEM).
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FIG. 1. Time course of mean (SEM) plasma (A) and CSF concentrations (B) of pancuronium before (O> A) and after
( • , A) osmotic disruption of the BBB. At 0 a 2 x ED,0 bolus dose was administered; continuous infusion from 18 to
78 min. Pancuronium concentrations in the CSF after BBB disruption were significantly greater (P < 0.05).
RESULTS
Haemodynamic and respiratory variables remained
stable throughout all experiments.
Unilateral common carotid artery ligation
Unilateral common carotid artery ligation pro-
duced no haemodynamic effects. In the three animals
subjected to this procedure, Evan's blue staining was
not detected 60 min after continuous ligation of the
CCA.
Concentration of pancuronium in the cerebrospinal
fluid before and after disruption of the blood-brain
barrier
There was no statistically significant difference in
plasma concentrations of pancuronium before and
after BBB disruption (fig. 1A). In contrast, after
osmotic disruption of the BBB a significantly greater
concentration of pancuronium was detected in CSF
(fig. 1B). The CSF:plasma ratio was 0.023, which is
significantly greater than the ratio of 0.005 before
disruption of the BBB.
Access to cerebrospinal fluid
Using the transoccipital approach, clear CSF
could be obtained in each case as required by the
study. Correct catheter position within the centre of
the cerebellomedullary cistern was confirmed at
autopsy.
Osmotic blood-brain barrier disruption
In all cases, reproducible Evan's blue staining of
the cortex (grade 2 + = moderate blue staining) was
obtained, which suggests that the desired degree of
BBB disruption was achieved with 25% mannitol
3 ml kg"1 injected into the CCA.
DISCUSSION
Osmotic disruption of the BBB by direct or retro-
grade infusion of hypertonic solutions into the
internal carotid artery has been standardized in small
rodents, monkeys and dogs [6, 9, 10]. In the pig, as
a result of certain anatomical differences in arterial
blood supply of the brain, only the CCA is accessible
for injection of hypertonic solutions. When this
approach is used for BBB disruption, continuous
CCA ligation may result, not only in BBB break-
down, but also in an increased incidence of apnoea,
bradycardia, hypotension or even permanent brain
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damage [11]. However, our preliminary studies
clearly showed that unilateral continuous CCA
ligation in the pig was not followed by undesired
haemodynamic responses and in no case was Evan's
blue staining detected in brain, even after a 60-min
period of continuous ligation. This demonstrates
that, in the pig, sufficient collateral cerebral cir-
culation is provided by the dense extradural arterial
network which is supplied by both CCA [12].
In earlier studies the injection of hypertonic
mannitol 1.5 ml kg"1 into the CCA in dogs resulted
in inconsistent BBB disruption because of a large
distal external to internal carotid collateral cir-
culation via the snout [10, 13]. Taking into account
the apparently larger capacity of the complex
cerebro-arterial system in the pig, in the present
study 25 % mannitol 3 ml kg"1 was used to produce
the desired degree of disruption. In all experiments
this was followed by a moderate Evan's blue staining
of both hemispheres, indicating osmotic breakdown.
Even minimal blood staining of CSF impedes
reliable qualitative and quantitative assessment of
drug transfer through the BBB. Although several
methods of access to the cerebral ventricular system
and the subarachnoid space of the cerebello-
medullary cistern have already been described in the
pig, frequent withdrawal of clear (not blood-stained)
CSF could not be guaranteed [14, 15]. When
stereotaxic insertion of the ventricular cannula is
used, CSF removal is frequently unsuccessful be-
cause of ventricular collapse or blocking 6f the
cannula by the choroid plexus. In addition,
stretching and distortion of choroid vessels by
suction may cause progressive bleeding and may
consequently lead to unintended mechanical damage
of the BBB. In the cerebellomedullary cistern, the
subarachnoid space is rather small and the distance
between the atlanto-occipital membrane and the
medulla oblongata is usually < 5 mm in pigs
weighing 20-22 kg. Thus a percutaneous technique
with subsequent puncture of the atlanto—occipital
membrane may not permit correct catheter posit-
ioning. A misplaced catheter may result immedi-
ately in a dry tap, disastrous puncture of the medulla
oblongata or blood-stained CSF as a result of damage
to pial vessels. In order to guarantee reliable access
to clear CSF, a retrograde approach to the cerebello-
medullary cistern has been developed and used
successfully in our experiments. Meticulous place-
ment of the occipital drill hole within the described
anatomical structures and careful movement of the
catheter in a medic—caudal direction has proved to be
of the utmost importance.
When studying the passage of any drug through
the BBB over a given period, it is essential that the
amount of CSF withdrawn for analysis does not
exceed its rate of production. There are no data
available for the rate of CSF formation in the pig,
butrassumingthe-rate is comparable ttrthatrin the
dog, withdrawal of 0.3-0.5 ml every 10 min is
reasonable [16].
The animal model described has been used
successfully to study the passage of pancuronium
from blood to CSF. Despite being ionized, i.v.
administered pancuronium passes into the CSF in
small amounts, the resulting CSF: plasma ratio being
very small. However, after BBB disruption a sig-
nificantly greater concentration of pancuronium was
detected in CSF.
In conclusion, the pig serves as an excellent model
for investigating the passage of drugs through the
intact and disrupted BBB. The data obtained from
this experimental model strongly suggest that i.v.
administered pancuronium might yield CSF concen-
trations large enough to affect the CNS when the
BBB is compromised. This should be considered
whenever neuromuscular blocking agents or other
drugs not thought to cross the BBB are administered
simultaneously with high-dose mannitol, for
example to enforce diuresis or to reduce rapidly an
increased intracranial pressure.
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